Zebra Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18,446
| Closed | -$438K | – | 275 |
|
|
2020
Q2 | $438K | Sell |
18,446
-4,296
| -19% | -$102K | 0.63% | 45 |
|
|
2020
Q1 | $409K | Sell |
22,742
-2,421
| -10% | -$43.5K | 0.66% | 48 |
|
|
2019
Q4 | $597K | Buy |
25,163
+11,559
| +85% | +$274K | 0.53% | 54 |
|
|
2019
Q3 | $373K | Buy |
13,604
+4,206
| +45% | +$115K | 0.41% | 88 |
|
|
2019
Q2 | $311K | Buy |
+9,398
| New | +$311K | 0.16% | 260 |
|